EX-FILING FEES 5 d277587dexfilingfees.htm EX-FILING FEES EX-FILING FEES

Exhibit 107

Calculation of Filing Fee Tables

Form S-3

(Form Type)

Orchard Therapeutics plc

(Exact Name of Registrant as Specified in its Charter)

Table 1: Newly Registered and Carry Forward Securities

 

                         
    

Security

Type

 

Security

Class

Title

 

Fee

Calculation

or Carry

Forward

Rule

 

Amount

Registered(2)

 

Proposed

Maximum

Offering

Price Per

Unit(3)

 

Maximum

Aggregate

Offering

Price

 

Fee

Rate

 

Amount of

Registration

Fee

 

Carry

Forward

Form

Type

 

Carry

Forward

File

Number

 

Carry

Forward

Initial

effective

date

 

Filing Fee

Previously

Paid In

Connection

with Unsold

Securities to
be Carried

Forward

 
Newly Registered Securities
                         

Fees to Be

Paid

  Equity(1)   Ordinary Shares, nominal value £0.10 per share   457(r)   $ —   $ —   $ —     $ —          
                         

Fees to Be

Paid

  Debt(1)   Debt Securities   457(r)                    
                         

Fees to Be

Paid

  Other(1)   Warrants   457(r)                    
                         

Fees to Be

Paid

  Other(1)   Units   457(r)                          
                         

Fees to Be

Paid

 

Unallocated

(Universal) Shelf(1)

      457(o)       $200,000,000   0.0000927   $18,540                

Fees to Be

Paid

  Total Registration Fee:               $18,540            
 
Carry Forward Securities
                         

Carry

Forward

Securities

  Equity   Ordinary Shares, nominal value £0.10 per share   457(b)   $100,000,000(4)   N/A   $100,000,000       POSASR  
333-234439
  February 27, 2020   $12,980
                   
    Total Offering Amounts         $18,540          
                   
    Total Fees Previously Paid                              
                   
    Total Fee Offsets         $12,980          
                   
    Net Fee Due               $5,560                


(1)

The amount to be registered consists of up to $200,000,000 of an indeterminate amount of ordinary shares, debt securities, warrants and/or units that may be offered and sold from time to time in one or more offerings. The ordinary shares may be represented by American Depositary Shares, each of which currently represents one ordinary share. A separate registration statement on Form F-6 has been or will be filed for the registration of American Depositary Shares issuable upon deposit of the ordinary shares.

(2)

Such indeterminate number or amount of ordinary shares, debt securities, warrants and/or units to purchase any combination of the foregoing securities, as may from time to time be issued at indeterminate prices, and units composed of one or more of the foregoing securities, with an aggregate initial offering price not to exceed $200,000,000. Securities registered hereunder may be sold separately or together in any combination with other securities registered hereunder. Warrants may be exercised to purchase any of the other securities registered hereby. The securities registered hereunder also include such indeterminate number of ordinary shares and amount of debt securities as may be issued upon conversion of or exchange for securities that provide for conversion or exchange, upon exercise of securities or pursuant to the antidilution provisions of any other securities.

(3)

The proposed maximum offering price per security will be determined from time to time by the registrant in connection with the issuance by the registrant of the securities registered hereunder and is not specified as to each class of security pursuant to General Instruction II.D. of Form S-3 under the Securities Act of 1933, as amended (the “Securities Act”).

(4)

The registrant previously paid a fee of $12,980 related to $100,000,000 of the registrant’s ordinary shares, which could have been represented by American Depositary Shares, that could have been issued and sold under a certain sales agreement with Cowen and Company, LLC pursuant to a prospectus supplement filed by the registrant on February 27, 2020. Of such shares, $100,000,000 were unsold, and the registration fee in the amount of $12,980 related thereto is applied to the registrant’s total registration fee. Accordingly, the registrant is paying the registration fee due less the $12,980 that was previously paid.

Table 2: Fee Offset Claims and Sources

 

                       
     

Registrant

or Filer

Name

  

Form

or

Filing

Type

  

File

Number

  

Initial

Filing

Date

  

Filing

Date

  

Fee Offset

Claimed

  

Security

Type

Associated

with Fee

Offset

Claimed

  

Security

Title

Associated

with Fee

Offset

Claimed

 

Unsold

Securities

Associated

with Fee

Offset

Claimed

  

Unsold

Aggregate

Offering

Amount

Associated

with Fee

Offset

Claimed

  

Fee Paid

with Fee

Offset

Source

 
Rule 457(b) and 0-11(a)(2)
                       

Fee Offset

Claims

                                 
                       

Fee Offset

Sources

   Orchard
Therapeutics
plc
   POSASR    333-234439    February 27,
2020
   February 27,
2020
   $12,980    Equity    American
Depositary
Shares
representing
Ordinary
Shares,
nominal
value £0.10
per share
  N/A    $100,000,000    $12,980
 
Rule 457(p)
                       
Fee Offset                                  
                       
Claims